Durable response using regorafenib in an elderly patient with metastatic colorectal cancer: case report

Regorafenib, an oral multikinase inhibitor, was approved in September 2012 by the US Food and Drug Administration for the treatment of patients with metastatic colorectal cancer. Since this time, however, few case reports outlining real-world usage have been published in the literature. Here, we det...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Ronald, Kain, Tatiana, Herman, June, Seery, Tara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657800/
https://www.ncbi.nlm.nih.gov/pubmed/26640390
http://dx.doi.org/10.2147/CMAR.S91547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657800/
https://www.ncbi.nlm.nih.gov/pubmed/26640390
http://dx.doi.org/10.2147/CMAR.S91547

Ejemplares similares